Skip to main content
Erschienen in: Pituitary 3/2014

01.06.2014

Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy

verfasst von: Carmela Caputo, Ali Bazargan, Penelope A. McKelvie, Tom Sutherland, Charles S. Su, Warrick J. Inder

Erschienen in: Pituitary | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fifteen cases of lymphocytic hypophysitis due to IgG4-related disease have been reported demonstrating marked improvement with corticosteroid therapy. This is the first case of IgG4-related hypophysitis demonstrating improvement with azathioprine, where corticosteroids were initially tried but ceased due to concern regarding enlargement of the pituitary infiltrate.

Methods

Case description and review of 15 cases reported in the literature. A 40 year old male was diagnosed with IgG-4 related disease based on pituitary and lacrimal gland biopsies associated with raised serum concentration of IgG4. The patient was commenced on prednisolone 30 mg/day, as rapid response to prednisolone treatment has been described in the literature for other cases of IgG4-related hypophysitis. Over the next 3 months, prednisolone treatment resulted in a reduction of serum IgG4 levels, but repeat MRI scan showed an enlarging pituitary mass with new optic nerve compression. Azathioprine 75 mg twice daily was commenced and in the subsequent 3 months, IgG4 levels normalised (0.58 g/L) and MRI scan showed 50 % shrinkage of the pituitary mass. After 10 months of azathioprine treatment the MRI showed a normal sized pituitary but persistence of the infraorbital nerve thickening.

Conclusions

Hypophysitis due to IgG4-related disease usually demonstrates prompt response to corticosteroids. This case highlights the need to image promptly after starting treatment to exclude an enlarging pituitary mass despite corticosteroid treatment. Alternative therapy with azathioprine can result in marked improvement. It should be remembered that IgG-4 related hypophysitis is part of a multi-organ disease.
Literatur
1.
Zurück zum Zitat Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthr Rheum 64(10):3061–3067CrossRef Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthr Rheum 64(10):3061–3067CrossRef
2.
Zurück zum Zitat Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22(1):1–14PubMedCentralPubMedCrossRef Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22(1):1–14PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192PubMedCrossRef Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192PubMedCrossRef
4.
Zurück zum Zitat Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES (2012) Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol 2012:232960PubMedCentralPubMedCrossRef Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES (2012) Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol 2012:232960PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732–738PubMedCrossRef Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732–738PubMedCrossRef
6.
Zurück zum Zitat Kamisawa T, Egawa N, Nakajima H (2003) Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 98(12):2811–2812PubMedCrossRef Kamisawa T, Egawa N, Nakajima H (2003) Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 98(12):2811–2812PubMedCrossRef
7.
Zurück zum Zitat van der Vliet HJ, Perenboom RM (2004) Multiple pseudotumor in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 141(11):896–897PubMedCrossRef van der Vliet HJ, Perenboom RM (2004) Multiple pseudotumor in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 141(11):896–897PubMedCrossRef
8.
Zurück zum Zitat Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al (2006) A case of Mikulicz’s disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand J Rheumatol 35(5):410–411PubMedCrossRef Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H et al (2006) A case of Mikulicz’s disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis. Scand J Rheumatol 35(5):410–411PubMedCrossRef
9.
Zurück zum Zitat Tanabe T, Tsushima K, Yasuo M, Urushihata K, Hanaoka M, Koizumi T et al (2006) IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med 45(21):1243–1247PubMedCrossRef Tanabe T, Tsushima K, Yasuo M, Urushihata K, Hanaoka M, Koizumi T et al (2006) IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement. Intern Med 45(21):1243–1247PubMedCrossRef
10.
Zurück zum Zitat Ralli S, Lin J, Farrell J (2007) Autoimmune pancreatitis. N Engl J Med 356(15):1586; author reply 7 Ralli S, Lin J, Farrell J (2007) Autoimmune pancreatitis. N Engl J Med 356(15):1586; author reply 7
11.
Zurück zum Zitat Wong S, Lam WY, Wong WK, Lee KC (2007) Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 38(11):1720–1723PubMedCrossRef Wong S, Lam WY, Wong WK, Lee KC (2007) Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 38(11):1720–1723PubMedCrossRef
12.
Zurück zum Zitat Isaka Y, Yoshioka K, Nishio M, Yamagami K, Konishi Y, Inoue T et al (2008) A case of IgG4-related multifocal fibrosclerosis complicated by central diabetes insipidus. Endocr J 55(4):723–728PubMedCrossRef Isaka Y, Yoshioka K, Nishio M, Yamagami K, Konishi Y, Inoue T et al (2008) A case of IgG4-related multifocal fibrosclerosis complicated by central diabetes insipidus. Endocr J 55(4):723–728PubMedCrossRef
13.
Zurück zum Zitat Tsuboi H, Inokuma S, Setoguchi K, Shuji S, Hagino N, Tanaka Y et al (2008) Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroid. Intern Med 47(12):1139–1142PubMedCrossRef Tsuboi H, Inokuma S, Setoguchi K, Shuji S, Hagino N, Tanaka Y et al (2008) Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroid. Intern Med 47(12):1139–1142PubMedCrossRef
14.
Zurück zum Zitat Osawa S, Ogawa Y, Watanabe M, Tominaga T (2009) Hypophysitis presenting with atypical rapid deterioration: with special reference to immunoglobulin G4-related disease-case report. Neurol Med Chir (Tokyo) 49(12):622–625CrossRef Osawa S, Ogawa Y, Watanabe M, Tominaga T (2009) Hypophysitis presenting with atypical rapid deterioration: with special reference to immunoglobulin G4-related disease-case report. Neurol Med Chir (Tokyo) 49(12):622–625CrossRef
15.
Zurück zum Zitat Hori M, Makita N, Andoh T, Takiyama H, Yajima Y, Sakatani T et al (2010) Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J 57(6):485–492PubMedCrossRef Hori M, Makita N, Andoh T, Takiyama H, Yajima Y, Sakatani T et al (2010) Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J 57(6):485–492PubMedCrossRef
16.
Zurück zum Zitat Haraguchi A, Era A, Yasui J, Ando T, Ueki I, Horie I et al (2010) Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J 57(8):719–725PubMedCrossRef Haraguchi A, Era A, Yasui J, Ando T, Ueki I, Horie I et al (2010) Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J 57(8):719–725PubMedCrossRef
17.
Zurück zum Zitat Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96(7):1971–1980PubMedCentralPubMedCrossRef Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96(7):1971–1980PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Patel SM, Szostek JH (2011) IgG4-related systemic disease in a Native American man. Intern Med 50(8):931–934PubMedCrossRef Patel SM, Szostek JH (2011) IgG4-related systemic disease in a Native American man. Intern Med 50(8):931–934PubMedCrossRef
19.
Zurück zum Zitat Hsing MT, Hsu HT, Cheng CY, Chen CM (2013) IgG4-related hypophysitis presenting as a pituitary adenoma with systemic disease. Asian J Surg 36(2):93–97PubMedCrossRef Hsing MT, Hsu HT, Cheng CY, Chen CM (2013) IgG4-related hypophysitis presenting as a pituitary adenoma with systemic disease. Asian J Surg 36(2):93–97PubMedCrossRef
20.
Zurück zum Zitat Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, et al (2013) A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 98(5):1808–1811 Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, et al (2013) A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 98(5):1808–1811
21.
Zurück zum Zitat Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A et al (2012) Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012:580814PubMedCentralPubMedCrossRef Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A et al (2012) Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012:580814PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Bosco JJ, Suan D, Varikatt W, Lin MW (2013) Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression. Intern Med J 43(4):417–423PubMedCrossRef Bosco JJ, Suan D, Varikatt W, Lin MW (2013) Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression. Intern Med J 43(4):417–423PubMedCrossRef
23.
Zurück zum Zitat Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 91(1):57–66CrossRef Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 91(1):57–66CrossRef
24.
Zurück zum Zitat Wong PC, Fung AT, Gerrie AS, Moloney G, Maberley D, Rossman D et al (2013) IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol 90(3):250–256PubMedCrossRef Wong PC, Fung AT, Gerrie AS, Moloney G, Maberley D, Rossman D et al (2013) IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol 90(3):250–256PubMedCrossRef
25.
Zurück zum Zitat Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Bruck W, Caturegli P et al (2006) Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol 155(1):101–107PubMedCrossRef Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Bruck W, Caturegli P et al (2006) Primary hypophysitis: clinical-pathological correlations. Eur J Endocrinol 155(1):101–107PubMedCrossRef
26.
Zurück zum Zitat Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26(5):599–614PubMedCrossRef Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26(5):599–614PubMedCrossRef
27.
28.
Zurück zum Zitat Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 45(5):471–477PubMedCrossRef Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 45(5):471–477PubMedCrossRef
29.
Zurück zum Zitat Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR et al (2007) Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 102(11):2417–2425PubMedCrossRef Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR et al (2007) Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 102(11):2417–2425PubMedCrossRef
Metadaten
Titel
Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy
verfasst von
Carmela Caputo
Ali Bazargan
Penelope A. McKelvie
Tom Sutherland
Charles S. Su
Warrick J. Inder
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 3/2014
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-013-0498-9

Weitere Artikel der Ausgabe 3/2014

Pituitary 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.